The research, published online Sunday in Nature Nanotechnology, is the first to show that scientists can detect unlabeled single DNA bases "to a confidence level … appropriate for a highly competitive commercial sequencing system," Oxford Nanopore's CEO said.
Researchers from the Murdoch Childrens Research Institute in Parkville, Australia, investigated the feasibility of replacing "time-consuming, locus-specific testing for specific microdeletion and microduplication syndromes with microarray analysis." Study co-author Howard Slater spoke with BioArray News about the paper.
Georgia Biotech Tort-Shield Legislation, Maryland Biotechnology Tax Credits, North Carolina Council for Entrepreneurial Development-Biotech 2009, Louisiana 2007 Science Education Act, Society for Integrative and Comparative Biology, Pittsburgh Life Sciences Greenhouse, Singapore Pharmaceutical Exports
The settlement terminates a licensing agreement signed between Rockefeller and Ligand in 1992 related to patents and know-how surrounding peptidyl hormone-mediated gene expression technology discovered primarily by a Rockefeller scientist.